Cargando…

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment

BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W, Tognella, Silvia, Bonadiman, Luca, Turco, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436709/
https://www.ncbi.nlm.nih.gov/pubmed/22958465
http://dx.doi.org/10.1186/2049-6958-7-15
_version_ 1782242676989493248
author Dal Negro, Roberto W
Tognella, Silvia
Bonadiman, Luca
Turco, Paola
author_facet Dal Negro, Roberto W
Tognella, Silvia
Bonadiman, Luca
Turco, Paola
author_sort Dal Negro, Roberto W
collection PubMed
description BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort of 132 severe COPD patients (94 males; 71.4 years ± 8.8 sd), newly admitted to the tele-LTOT program, was investigated. Subjects were divided according to their original blood Hb: group A: <13 g/dL; group B: ≥13 < 15 g/dL; group C: ≥ 5 < 16 g/dL; group D: ≥16 g/dL. Blood Hb (g/dL), PaO(2) and PaCO(2) (mmHg), SaO(2) (%), and BMI were measured at LTOT admission (t(0)), and at least quarterly over three years (t(1)-t(3)). Wilcoxon test was used to compare t(0) vs. t(1) values; linear regression to assess a possible Hb-BMI relationship; ANOVA to compare changes in Hb time-courses over the 3 years. RESULTS: LTOT induced a systematic increase of PaO(2), and changes were significant since the first year (from 52.1 mmHg ± 6.6sd to 65.1 mmHg ± 8.7 sd, p < 0.001). Changes in SaO(2) were quite similar. Comparable and equally significant trends were seen in all subgroups (p < 0.001). PaCO(2) dropped within the first year of LTOT (from 49.4 mmHg ± 9.1sd to 45.9 mmHg ±7.5 sd, p < 0.001): the t(0)-t(1) comparison proved significant (p < 0.01) only in subgroups with the highest basal Hb, who showed a further PaCO(2) decline over the remaining two years (p < 0.001). Hb tended to normalization during LTOT only in subgroups with basal Hb > 15 g/dl (ANOVA p < 0.001); anemic subjects (Hb < 13 g/dl) ameliorated not significantly in the same period (ANOVA = 0.5). Survival was independent of the original blood Hb. Anemia and polyglobulia are differently prevalent in COPD, the latter being the most represented in our cohort. LTOT affected both conditions, but to a different extent and according to different time-courses. The most striking Hb improvement was in polyglobulic patients in whom also PaO(2), PaCO(2) and SaO(2) dramatically improved. In anemic subjects effects were smaller and slower, oxygenation being equally ameliorated by LTOT. CONCLUSIONS: LTOT effects on Hb and PaCO(2) are regulated by an Hb-dependent gradient which seems independent of the original impairment of blood gases and of effects on oxygenation.
format Online
Article
Text
id pubmed-3436709
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34367092012-09-08 Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment Dal Negro, Roberto W Tognella, Silvia Bonadiman, Luca Turco, Paola Multidiscip Respir Med Original Article BACKGROUND: Information on the effects of long-term oxygen treatment (LTOT) on blood hemoglobin (Hb) in severe COPD are limited. The aim was to assess blood Hb values in severe COPD, and investigate the time-course of both Hb and blood gas changes during a 3-year telemetric LTOT. METHODS: A cohort of 132 severe COPD patients (94 males; 71.4 years ± 8.8 sd), newly admitted to the tele-LTOT program, was investigated. Subjects were divided according to their original blood Hb: group A: <13 g/dL; group B: ≥13 < 15 g/dL; group C: ≥ 5 < 16 g/dL; group D: ≥16 g/dL. Blood Hb (g/dL), PaO(2) and PaCO(2) (mmHg), SaO(2) (%), and BMI were measured at LTOT admission (t(0)), and at least quarterly over three years (t(1)-t(3)). Wilcoxon test was used to compare t(0) vs. t(1) values; linear regression to assess a possible Hb-BMI relationship; ANOVA to compare changes in Hb time-courses over the 3 years. RESULTS: LTOT induced a systematic increase of PaO(2), and changes were significant since the first year (from 52.1 mmHg ± 6.6sd to 65.1 mmHg ± 8.7 sd, p < 0.001). Changes in SaO(2) were quite similar. Comparable and equally significant trends were seen in all subgroups (p < 0.001). PaCO(2) dropped within the first year of LTOT (from 49.4 mmHg ± 9.1sd to 45.9 mmHg ±7.5 sd, p < 0.001): the t(0)-t(1) comparison proved significant (p < 0.01) only in subgroups with the highest basal Hb, who showed a further PaCO(2) decline over the remaining two years (p < 0.001). Hb tended to normalization during LTOT only in subgroups with basal Hb > 15 g/dl (ANOVA p < 0.001); anemic subjects (Hb < 13 g/dl) ameliorated not significantly in the same period (ANOVA = 0.5). Survival was independent of the original blood Hb. Anemia and polyglobulia are differently prevalent in COPD, the latter being the most represented in our cohort. LTOT affected both conditions, but to a different extent and according to different time-courses. The most striking Hb improvement was in polyglobulic patients in whom also PaO(2), PaCO(2) and SaO(2) dramatically improved. In anemic subjects effects were smaller and slower, oxygenation being equally ameliorated by LTOT. CONCLUSIONS: LTOT effects on Hb and PaCO(2) are regulated by an Hb-dependent gradient which seems independent of the original impairment of blood gases and of effects on oxygenation. BioMed Central 2012-07-17 /pmc/articles/PMC3436709/ /pubmed/22958465 http://dx.doi.org/10.1186/2049-6958-7-15 Text en Copyright ©2012 Dal Negro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dal Negro, Roberto W
Tognella, Silvia
Bonadiman, Luca
Turco, Paola
Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title_full Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title_fullStr Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title_full_unstemmed Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title_short Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
title_sort changes in blood hemoglobin and blood gases pao(2) and paco(2) in severe copd overa three-year telemonitored program of long-term oxygen treatment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436709/
https://www.ncbi.nlm.nih.gov/pubmed/22958465
http://dx.doi.org/10.1186/2049-6958-7-15
work_keys_str_mv AT dalnegrorobertow changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment
AT tognellasilvia changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment
AT bonadimanluca changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment
AT turcopaola changesinbloodhemoglobinandbloodgasespao2andpaco2inseverecopdoverathreeyeartelemonitoredprogramoflongtermoxygentreatment